STEMI

·MeSH: Coronary Artery Disease

151 drugs in development·76 companies·1 clinical trial

Drug Pipeline by Phase

Approved(28)

Drug	Company
abrilada	PFIZER INC (PFE)
acitretin	Mylan II B.V. (MYL)
apixaban	Mylan II B.V. (MYL)
apixaban	Impax Laboratories, LLC (IPXL)
axitinib	Aptinyx Inc. (APTX)
ayvakit	Blueprint Medicines Corp (BPMC)
bexarotene	ANI PHARMACEUTICALS INC (ANIP)
chenodiol	Optec International, Inc. (GM)
cibinqo	PFIZER INC (PFE)
clopidogrel bi	DR REDDYS LABORATORIES LTD (RDY)
clopidogrel bi	Teva Pharmaceutical Industries Limited (TEVA)
emrelis	AbbVie Inc. (ABBV)
etorel	GYRE THERAPEUTICS, INC. (GYRE)
fluconazole	ANI PHARMACEUTICALS INC (ANIP)
imuldosa	Acorda Therapeutics, Inc. (ACOR)
istodax	BRISTOL MYERS SQUIBB CO (BMY)
jaypirca	LOXO ONCOLOGY, INC. (LOXO)
Jaypirca	ELI LILLY & Co (LLY)
Jaypirca®	ELI LILLY & Co (LLY)
krazati	BRISTOL MYERS SQUIBB CO (BMY)
prasugrel	Mylan II B.V. (MYL)
tofidence	BIOGEN INC. (BIIB)
treprostinil	Teva Pharmaceutical Industries Limited (TEVA)
trodelvy	Immunome Inc. (IMNM)
ursodiol	Optec International, Inc. (GM)
wezlana	AMGEN INC (AMGN)
yesintek	Bone Biologics Corp (BBLG)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)	Merus N.V. (MRUS)

Phase 3(34)

Drug	Company
AZD0120	ASTRAZENECA PLC (AZN)
bezuclastinib (CGT9486)	Cogent Biosciences, Inc. (COGT)
cenerimod	Innovation Pharmaceuticals Inc. (IPIX)
Cenerimod	Crinetics Pharmaceuticals, Inc. (CRNX)
dapirolizumab pegol	BIOGEN INC. (BIIB)
dapirolizumab pegol	POINT Biopharma Global Inc. (PNT)
dapirolizumab pegol	GT Biopharma, Inc. (GTBP)
Dapirolizumab Pegol	NEKTAR THERAPEUTICS (NKTR)
dnth212	Dianthus Therapeutics, Inc. /DE/ (DNTH)
dzp	POINT Biopharma Global Inc. (PNT)
dzp	GT Biopharma, Inc. (GTBP)
ESK-001	ALUMIS INC. (ALMS)
fludarabine	Juno Therapeutics, Inc. (JUNO)
Fludarabine	BRISTOL MYERS SQUIBB CO (BMY)
ianalumab	Novartis AG (NVS)
Ianalumab	Novartis AG (NVS)
ianalumab s.c. q12w	Novartis AG (NVS)
ianalumab s.c. q4w	Novartis AG (NVS)
iloprost	GT Biopharma, Inc. (GTBP)
ixazomib	X4 Pharmaceuticals, Inc (XFOR)
ixazomib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
kite-439	Kite Pharma, Inc. (KITE)
kite-585	Kite Pharma, Inc. (KITE)
kite-718	Kite Pharma, Inc. (KITE)
kite-796	Kite Pharma, Inc. (KITE)
Litifilimab	BIOGEN INC. (BIIB)
Medi-546	ASTRAZENECA PLC (AZN)
nintedanib	Juno Therapeutics, Inc. (JUNO)
sar448501	Sanofi (SNYNF)
Tocilizumab	BRISTOL MYERS SQUIBB CO (BMY)
Tocilizumab	ELI LILLY & Co (LLY)
UCAR-T cells	Filana Therapeutics Inc. (FLNA)
ziltivekimab	Novo Nordisk A/S (NVO)
Zipalertinib (CLN-081/TAS6417)	Cullinan Therapeutics, Inc. (CGEM)

Phase 2(35)

Drug	Company
10 mg/kg cm-101	Chemomab Therapeutics Ltd. (CMMB)
afimetoran	BRISTOL MYERS SQUIBB CO (BMY)
alpn-101	ALPINE IMMUNE SCIENCES, INC. (ALPN)
anifrolumab	Valneva SE (VALN)
AUCATZYL/obe-cel	Autolus Therapeutics plc (AUTL)
belimumab 10mg/kg	GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
Bezuclastinib	Cogent Biosciences, Inc. (COGT)
cc-97540	Juno Therapeutics, Inc. (JUNO)
CC-97540	BRISTOL MYERS SQUIBB CO (BMY)
cd19	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
cfz533	Novartis AG (NVS)
glpg3667	Galapagos NV (GLPG)
GLPG3667	Galapagos NV (GLPG)
hzn-825 bid	AMGEN INC (AMGN)
hzn-825 qd	AMGEN INC (AMGN)
iberdomide	CELGENE CORP /DE/ (CELG)
imvotamab	IGM Biosciences, Inc. (IGMS)
inebilizumab	AMGEN INC (AMGN)
Kevzara	REGENERON PHARMACEUTICALS, INC. (REGN)
mb-cart19.1	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
MK-1045	Merck & Co., Inc. (MRK)
MTX-474	Crinetics Pharmaceuticals, Inc. (CRNX)
MTX-474	Valneva SE (VALN)
prv-3279	Sanofi (SNYNF)
prv-3279	Sanofi (SNY)
prv-3279	PROVENTION BIO, INC. (PBI)
PRV-3279	MACROGENICS INC (MGNX)
rese-cel	Cabaletta Bio, Inc. (CABA)
sar441344 iv	Sanofi (SNY)
sar441344 iv	Sanofi (SNYNF)
sar441344 sc	Sanofi (SNYNF)
sar441344 sc	Sanofi (SNY)
tibulizumab	Zura Bio Ltd (ZURA)
Vasculan	CUMBERLAND PHARMACEUTICALS INC (CPIX)
Vasculan®	CUMBERLAND PHARMACEUTICALS INC (CPIX)

Phase 1(24)

Drug	Company
abbv-519	AbbVie Inc. (ABBV)
ace-1334	ACCELERON PHARMA INC (XLRN)
ALLO-329	Allogene Therapeutics, Inc. (ALLO)
AZD0120	Merus N.V. (MRUS)
blinatumomab	AMGEN INC (AMGN)
cenerimod	Viatris Inc (VTRS)
cnty-101	Century Therapeutics, Inc. (IPSC)
cnty-308	Century Therapeutics, Inc. (IPSC)
cnty-341	Century Therapeutics, Inc. (IPSC)
cnty-813	Century Therapeutics, Inc. (IPSC)
il-2	Century Therapeutics, Inc. (IPSC)
LUCAR-G79D T cells	Legend Biotech Corp (LEGN)
lymphodepleting chemotherapy	Century Therapeutics, Inc. (IPSC)
nkx019	Nkarta, Inc. (NKTX)
NKX019	Filana Therapeutics Inc. (FLNA)
obecabtagene autoleucel	Autolus Therapeutics plc (AUTL)
pit565	Novartis AG (NVS)
pit565	Novartis AG (NVS)
prula-cel	Adicet Bio, Inc. (ACET)
pt101	Pandion Therapeutics, Inc. (PAND)
rese-cel (resecabtagene autoleucel)	Cabaletta Bio, Inc. (CABA)
sar448501	Sanofi (SNY)
tocilizumab	Juno Therapeutics, Inc. (JUNO)
vib7734	Viela Bio, Inc. (VIE)

Preclinical(5)

Drug	Company
eb07	Edesa Biotech, Inc. (EDSA)
eb201	Estrella Immunopharma Inc. (ESLA)
gri-0803	GRI Bio, Inc. (GRI)
inb-619	IN8BIO, INC. (INAB)
IRF5 program	ALUMIS INC. (ALMS)

N/A(1)

Drug	Company
LockBody technology platform	Centessa Pharmaceuticals plc (CNTA)

Phase 1/Phase 2(15)

Drug	Company
alpn-303	ALPINE IMMUNE SCIENCES, INC. (ALPN)
anti-cd19 car t cell therapy	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
CABA-201	Cabaletta Bio, Inc. (CABA)
CTX112	CRISPR Therapeutics AG (CRSP)
descartes-08	Cartesian Therapeutics, Inc. (RNAC)
fludarabine	Nkarta, Inc. (NKTX)
Fludarabine	ASTRAZENECA PLC (AZN)
gc012f	SQZ Biotechnologies Co (SQZB)
kyv-101	Kyverna Therapeutics, Inc. (KYTX)
rapcabtagene autoleucel	Novartis AG (NVS)
standard lymphodepletion regimen	Kyverna Therapeutics, Inc. (KYTX)
syn-020	Theriva Biologics, Inc. (TOVX)
ytb323	Novartis AG (NVS)
YTB323	Novartis AG (NVS)
zugo-cel	CRISPR Therapeutics AG (CRSP)

Phase 2/Phase 3(4)

Drug	Company
AZD5492	ASTRAZENECA PLC (AZN)
blu-263	Blueprint Medicines Corp (BPMC)
elenestinib	Blueprint Medicines Corp (BPMC)
tecarfarin	Cadrenal Therapeutics, Inc. (CVKD)

Phase 4(5)

Drug	Company
Anifrolumab	ASTRAZENECA PLC (AZN)
avapritinib	Blueprint Medicines Corp (BPMC)
bms-986165	BRISTOL MYERS SQUIBB CO (BMY)
single	GH Research PLC (GHRS)
Upadacitinib	AbbVie Inc. (ABBV)

BioSniper tracks 151 drugs in development for STEMI across 76 companies.

There are 1 clinical trial targeting STEMI tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.